Hometown: San Jose, California
Faculty mentor: Sanjana Dayal, PhD, associate professor of internal medicine-hematology, oncology, and blood and marrow transplantation, Department of Internal Medicine, Carver College of Medicine
Degree program and anticipated graduation date: MD, Class of 2025

Srija Manchkanti’s research focuses on understanding the effects of estrogen therapy on heart, kidney, liver, and metabolic health in women. Using a large global database, Manchkanti examined the prevalence of conditions like hypertension, heart failure, liver disease, and diabetes in patients receiving estrogen treatments. She found that cisgender women on estrogen had higher rates of these conditions, while transgender women had a higher prevalence of high cholesterol and obesity. By identifying the differing long-term health effects of estrogen across different populations, Manchkanti paves the way for medical professionals to improve outcomes for patients receiving estrogen therapy.

After graduation, Manchkanti plans to pursue a residency in internal medicine, with the long-term goal of specializing in hematology-oncology. She hopes to combine clinical care with research to contribute to advancing treatment options in cancer care through clinical trials and improving patient outcomes.

Banner location: Downtown—